Security key
221413305
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 326,383
- Total 13F value
- $60,283
- Share change
- +12,241
- SEC-reported price per share
- $0.18
- Number of holders
- 6
- Value change
- +$2,260
- Number of buys
- 3
- Number of sells
- 1
- Shares outstanding
- 37,334,120
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
6
Top holders
6
COSM full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q3 2025
Cosmos Health Inc. SEC filings
Cosmos Health Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 221413305
Recent filing periods:
Ownership snapshot
Top reported holders of COSM - Cosmos Health Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Grigorios Siokas
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
05 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 23%
13D/G row: Grigorios Siokas
Showing 1-6 of 15 holder rows.
Quick read
Grigorios Siokas leads the comparable SEC ownership view at 23%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Grigorios Siokas's linked filing trail.
Comparable ownership
Top 5
Grigorios Siokas
23%
Bovopoulos Andreas
7.2%
ARMISTICE CAPITAL, LLC
5%
Anastasios Aslidis
0.27%
Suhel Bhutawala
0.17%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Grigorios Siokas |
13D/G
|
23%
|
—
6,871,267 shares
|
$0 | 21 Apr 2025 |
| Bovopoulos Andreas |
13D/G
|
7.2%
|
—
4,324,197 shares
|
$0 | 05 Jun 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$664,571
1,582,313 shares
|
-$140,867 | 30 Jun 2025 |
| Anastasios Aslidis |
3/4/5
Director
|
0.27%
|
$31,720
100,000 shares
|
— | 19 May 2026 |
| Suhel Bhutawala |
3/4/5
Director
|
0.17%
|
$20,618
65,000 shares
|
— | 19 May 2026 |
| Demetrios G. Demetriades |
3/4/5
Secretary, Director
|
0.15%
|
$17,446
55,000 shares
|
— | 19 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
326,383
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q3 2025 Across Filers
Q3 2025 holders
22
Q2 2026 holders
6
Holder diff
-16
| Investor | Q3 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend